The NAVREF "In Case You Missed It (ICYMIT)" is where you can find updates and announcements from NAVREF and stakeholders alike. Refer to this page if you want more in depth information on topics found in your weekly email briefs.
As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcement/Funding Opportunity is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC). The CDMRP provides execution management support for DHP core research program areas, including the Joint Program Committee 6/Combat Casualty Care Research Program (JPC-6/CCCRP), as the CDMRP Defense Medical Research and Development Program (DMRDP).
The DMRDP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY19 DMRDP Program Announcement and General Application Instructions for the following award mechanism is anticipated to be posted on the Grants.gov website in October 2018. Pre-application and application deadlines will be available when the Program Announcement is released. This pre-announcement should not be construed as an obligation by the government.
http://cdmrp.army.mil/pubs/press/2018/18dmrdppreann_jpc6
Multi-Domain Life-Saving Trauma Innovations
Independent investigators at all academic levels (or equivalent)
· Preproposal is required; application submission is by invitation only.
· The intent of the “Multi-Domain Life-Saving Trauma Innovations” (MuLTI) effort is to provide cutting-edge medical solutions for the Warfighter.
· Focus Areas will derive from the following JPC-6/CCCRP portfolios:
○ Battlefield Resuscitation for Immediate Stabilization of Combat Casualties
○ Neurotrauma and Traumatic Brain Injury
Prolonged Field Care and En Route Care
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcement and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for the award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Submission deadlines are not available until the Program Announcements are released. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the DMRDP, JPC-6/CCCRP, or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).
Point of Contact:
The FY18 Defense Appropriation provides $125 million (M) to the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (PH/TBIRP) to support critical traumatic brain injury (TBI)- and psychological health (PH)-related research and development efforts to benefit Service members, Veterans, and other beneficiaries of the military health system. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) J9, Research and Development Directorate, manages the Defense Health Program’s Research, Development, Test, and Evaluation appropriation. The U.S. Army Medical Research and Materiel Command (USAMRMC) Congressionally Directed Medical Research Programs (CDMRP) provides execution management support for DHA research program areas, including the Joint Program Committee-8/Clinical and Rehabilitative Medicine Research Program (JPC-8/CRMRP). The managing agent for this Program Announcement is the CDMRP with strategic oversight from the JPC-8/CRMRP.
The FY18/19 PH/TBIRP will solicit research applications for the following CTRR Focus Areas:
Ecological Assessment: Investigation of outcome measures focused on military-specific tasks that inform return-to-duty/participation decisions following rehabilitation in patients with TBI.
Cognitive Rehabilitation: Evaluation of rehabilitation intervention effectiveness in remediating cognitive impairments and functional limitations after TBI.
https://www.grants.gov/web/grants/search-grants.html
CTRR – Clinical Research Award (CTRR-CRA) – Preproposal due September 24, 2018
· Supports applied and translational research to advance the development of knowledge and materiel products for rehabilitation and restoration of function following TBI.
· Supported research can include preclinical studies using human subjects or samples and observational or mechanistic clinical research studies.
· Clinical trials are not allowed.
· Preclinical research using animals is not allowed.
· Must address one or more FY18/19 PH/TBIRP CTRR Focus Areas.
Preproposal is required; application submission is by invitation only.
· Maximum funding of $2.0M for total costs (includes direct and indirect costs).
CTRR – Clinical Trial Award (CTRR-CTA) – Preproposal due September 24, 2018
· Supports small, single-site, Phase I clinical trials to advance the development of knowledge and materiel products for rehabilitation and restoration of function following TBI in Service members, Veterans, and other individuals.
· Interventions should be limited, existing, and manualized. Studies may include seeking to optimize dosing in existing interventions.
· Preclinical studies are not allowed.
CTRR – Clinical Trial Development Award (CTRR-CTDA) – Preproposal due September 24, 2018
· Supports design and development of the necessary research resources that will serve as a foundation for investigator-initiated clinical trials as described above under CTRR – Clinical Trial Award (CTRR-CTA)
· Final supporting studies required for approval of Investigational New Drug Applications/Investigational Device Exemptions (IND/IDE-enabling) are allowed. Other preclinical studies are not allowed.
· Clinical trials are not allowed within the period of performance of the CTRR-CTDA.
· Maximum funding of $200,000 for total costs (includes direct and indirect costs).
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism is also on Grants.gov. A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the PH/TBIRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).
CDMRP Help Desk
The FY18 AIMM Program Announcement and General Application Instructions are posted on Grants.gov.
As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) Research and Development Directorate (J9) manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).
http://cdmrp.army.mil/funding/dmrdp
AIMM Research Award – is due September 19, 2018
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcement and General Application Instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism is also found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Applications must be submitted through the federal government’s single-entry portal, Grants.gov. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).
The FY18 Defense Appropriation provides $21 million (M) to the Department of Defense Gulf War Illness Research Program (GWIRP) to support high-impact research that will identify effective treatments and accelerate their clinical application, identify objective markers for improved definition and diagnosis, and/or provide a better understanding of the pathobiology underlying the complex of Gulf War Illness symptoms. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC).
FY18 GWIRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.
http://cdmrp.army.mil/funding/gwirp
New Investigator Award – Letter of Intent due October 18, 2018
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Applications must be submitted through the federal government’s single-entry portal, Grants.gov. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the GWIRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).
The FY18 Defense Appropriation provides $15 million (M) to the Department of Defense Vision Research Program (VRP) to support innovative, high-impact vision research. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC).
FY18 VRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.
Focused Translational Team Science Award (FTTSA) – Preproposal due September 4, 2018
PIs must be independent investigators at or above the level of Associate Professor (or equivalent) with experience in developing and running large-scale initiatives.
Investigator Initiated Research Award (IIRA) – Preproposal due September 4, 2018
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the VRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).
FY18 BCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on Grants.gov.
As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA), J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).
Applications submitted to the FY18 BCRP must address one or more of the following overarching challenges:
http://cdmrp.army.mil/funding/bcrp
Breakthrough Award Level 1 & 2– Letter of Intent due November 1, 2018
Breakthrough Award Level 3 & 4– Preproposal due September 14, 2018
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism is also found on Grants.gov. A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Applications must be submitted through the federal government’s single-entry portal, Grants.gov. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the BCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).
The FY18 Defense Appropriation provides $125 million (M) to the Department of Defense Psychological Health and Traumatic Brain Injury Research Program (PHTBIRP) to support specific Defense Health Agency (DHA) J9 Directorate research program areas, including Joint Program Committee-5/Military Operational Medicine Research Program (JPC-5/MOMRP). As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the DHA J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcement/Funding Opportunity is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC).
The PH/TBIRP and JPC-5/MOMRP are providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY18 PHTBIRP Program Announcement and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website in August 2018. Pre-application and application deadlines will be available when the Program Announcement is released. This pre-announcement should not be construed as an obligation by the government.
http://cdmrp.army.mil/pubs/press/2018/18phtbipreann_r2oe
Resiliency and Readiness Optimization/ Enhancement (R2OE)Translational Research Award
Intramural (DoD) and extramural investigators at all academic levels (or equivalent) are eligible to submit applications
Proposals/applications to the FY18 PHTBIRP R2OE Translational Research award should support research with the goal of evaluating evidence-based interventions and techniques to optimize and enhance resilience and psychological health readiness of Service members (SM). The expectation of this research is to demonstrate the utility of these resiliency and readiness enhancement interventions and techniques to benefit our SMs and the public at large.
· The maximum period of performance is 3 years.
The maximum allowable total costs per award (direct and indirect) for the entire period of performance is $3M
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Submission deadlines are not available until the Program Announcements are released. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the PHTBIRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).
The GWIRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY18 PRCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website in August 2018. Pre-application and application deadlines will be available when the Program Announcement is released. This pre-announcement should not be construed as an obligation by the government.
http://cdmrp.army.mil/pubs/press/2018/18gwirppreann_nia
The following mechanism is planned for release:
New Investigator Award
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Applications must be submitted through the federal government’s single-entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the GWIRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).
The FY18 Defense Appropriation provides $12 million (M) to the Department of Defense Reconstructive Transplant Research Program (RTRP) to support research projects that specifically address needs in the field of vascularized composite allotransplantation (VCA). The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC).
FY18 RTRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.
Focus Areas: The FY18 RTRP encourages research projects that specifically address needs in the field of vascularized composite allotransplantation (VCA) in the following focus areas:
http://cdmrp.army.mil/funding/rtrp
Concept Award (CA) – Letter of Intent due 10/3/18
Investigators at or above the level of postdoctoral fellow (or equivalent)
· Maximum funding of $200,000 for total costs (direct plus indirect costs)
Investigator-Initiated Research Award (IIRA) – Preproposal due 8/15/18
Individual PIs:
· Maximum funding of $1 million (M) for total costs
· Maximum period of performance is 3 years
Multiple PI Option:
· Maximum funding of $1.5M for total costs
Qualitative Research Award (QRA) – Preproposal due 8/15/18
○ Identify near- and long-term functional, quality-of-life, and psychosocial outcomes in VCA
Multiple PI Option supports synergistic partnerships among two to four investigators collaborating on a single application; multi-institutional collaborations are encouraged.
· Maximum funding of $1M for total costs
For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the RTRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).
NAVREF was recently recognized for our transparency with a 2018 Gold Seal on our GuideStar Nonprofit Profile!
GuideStar is the world’s largest source of information on nonprofit organizations. More than 8 million visitors per year and a network of 200+ partners use GuideStar data to grow support for nonprofits.
In order to get the 2018 Gold Seal, NAVREF shared important information with the public using our profile on www.guidestar.org. Now our community members and potential donors can find in-depth information about our goals, strategies, capabilities, and progress. We’re shining a spotlight on the difference we help make in the world.
Don't believe us? Check out our profile on GuideStar or look at our logo at the footer of our website.
1717 K ST NW Suite 900
Washington, DC 20006
admin@navref.org
FEIN: 52-1784596
About NAVREF
About Our Members
Member Resources